Véronique Leblond
Sorbonne Université(FR)Assistance Publique – Hôpitaux de Paris(FR)Pitié-Salpêtrière Hospital(FR)Hôpital Charles-Foix(FR)
Publications by Year
Research Areas
Chronic Lymphocytic Leukemia Research, Lymphoma Diagnosis and Treatment, Immunodeficiency and Autoimmune Disorders, Viral-associated cancers and disorders, Acute Lymphoblastic Leukemia research
Most-Cited Works
- → High-Dose Therapy and Autologous Peripheral Blood Stem Cell Transplantation in Multiple Myeloma: Up-front or Rescue Treatment? Results of a Multicenter Sequential Randomized Clinical Trial(1998)539 cited
- → High-Dose Melphalan versus Melphalan plus Dexamethasone for AL Amyloidosis(2007)514 cited
- → A randomized phase 3 trial of zanubrutinib vs ibrutinib in symptomatic Waldenström macroglobulinemia: the ASPEN study(2020)438 cited
- → International prognostic scoring system for Waldenström macroglobulinemia(2009)406 cited
- → High-Dose Therapy and Autologous Blood Stem-Cell Transplantation Compared With Conventional Treatment in Myeloma Patients Aged 55 to 65 Years: Long-Term Results of a Randomized Control Trial From the Group Myelome-Autogreffe(2005)400 cited
- → Sequential treatment with rituximab followed by CHOP chemotherapy in adult B-cell post-transplant lymphoproliferative disorder (PTLD): the prospective international multicentre phase 2 PTLD-1 trial